Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

📅 28/07/2026 13:10 📰 biospace 👁️ 0 lectures 🌍 États-Unis 📂 Actualités